In a study involving 291 patients at risk of PCa or under active surveillance, the link between TMPRSS2: ERG, PCA3, PSA density, genetic variants, and androgenic status and biopsy pathological findings, was examined. The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.